The pharmaceutical formulation of Althesin was shown to have a weak allergenic potential in the guineapig maximization test. Alphadolone and alphaxalone acetate were found to be devoid of such potential, while the status of Cremophor EL remained equivocal.
ing from 300 to 400 g at the start of the experiment and originating from standard breedings (IffaCredo, l'Arbresle, France) were maintained under recommended conditions. Groups of 10 male and female guineapigs were used for each experiment.
Experimental procedure
All animals were submitted to an intradermal sensitization test, performed with two intradermal injections of Freund's complete adjuvant as described previously (Magnusson and Kligman, 1969; Brulosetal., 1977) . During the induction period, 10 repeated intradermal applications of the substance (0.5 ml per animal) were performed on the skin on the back of the guineapigs. An occlusive bandage was applied for 48 h. After a 12-day rest period, guineapigs were challenged on the abdomen, using the maximum dose which had not caused any orthoergic skin reaction in preliminary studies. Fortyeight hours later, the macroscopic cutaneous response was evaluated, according to a classical scale for erythematous and oedematous lesions (Draize, Woodgard and Calvery, 1944) . The macroscopic examination was negative (no allergy) when the score was equal to or less than the score obtained following the first intradermal application. Otherwise, the examination was considered doubtful and a histological examination was undertaken to obtain specific evidence of an allergic reaction, such as skin infiltration with lymphocytes and plasmocytes.
RESULTS
Cremophor EL, alphadolone and alphaxalone acetate were found to be devoid of any sensitizing capacity. In contrast, the pharmaceutical formulation of Althesin behaved as a weak sensitizer when the appropriate area of skin was examined histologically.
© The Macmillan Press Ltd 1983 The tniineao Not sensitizing a commonly used procedure for predicting the allergenic potential of chemicals (Maurer et al., 1978; Maurer, Weirich and Hess, 1980) and, despite difficulties of extrapolation from animals to man, these authors consider that even a low level of allergenicity can be detected (Maurer et al., 1979) .
In the present experiment, Althesin proved to be allergenic and this is in agreement with the hypothesis of an immune-mediated hypersensitivity reaction in clinical practice (Fisher, 1976; Watkins et al., 1976) . That Althesin was allergenic, in contrast to any of its constituents, is apparently paradoxical. However, it should be stressed that, unlike most authors, we assessed the allergenic potential from histological findings and not merely from macroscopic examination. According to the less severe standards, both Althesin and Cremophor EL would have been considered as medium range sensitizers (Maurer, Weirich and Hess, 1980) . We believe that the predictive value of the test is enhanced when taking the macroscopic and the histological findings into account simultaneously.
The results indicate that Althesin should be considered as a drug with a weak allergenic potential, while alphadolone and alphaxalone cannot be incriminated as such. In contrast with the experimental work of Glenn and co-workers (1979) , who showed the involvement of Cremophor in a mini-pig model, the status of Cremophor remains illestablished in our study. However, the mini-pig model was designed to mimic human "pseudoallergic" reactions to Althesin, whereas the maximization test was performed to detect an immunemediated mechanism and this may be the explanation for this discrepancy.
Thus an immune-mediated phenomenon should be considered as one of the mechanisms involved in Althesin-related hypersensitivity reactions.
